Featured Research

from universities, journals, and other organizations

Mathematical Model Identifies Genes Which Battle Hepatitis C

Date:
July 19, 2007
Source:
University of Haifa
Summary:
A cooperative research project between the University of Haifa and Indiana University yielded the discovery of a mathematical model which identifies genes which battle viruses. Using the method, researchers successfully identified 37 out of 22,000 genes which are active in the battle against the virus hepatitis C, which attacks the liver.

Joint research by Dr. Leonid Brodsky, of the Institute of Evolution of the University of Haifa, and Dr. Milton Taylor, of Indiana University, led to the discovery of a mathematical method which can identify which genes in our bodies conduct the battle against the various viruses that attack us. In their research, they identified 37 genes out of 22,000 possible genes which fight the hepatitis C virus, which attacks the liver.

"When we know which genes are responsible for fighting the viruses which attack our liver, we will be able to look for the medications which will activate these genes most favorably," said Dr. Brodsky. The team conducted clinical trials, supported by the Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH), which included 400 patients at eight different centers in the United States.

The hepatitis C virus, found mostly among many patients who have had a blood transfusion or who share needles, attacks the liver and in extreme cases can cause cancer of the liver. At present, there is one well know medication, interferon, used to treat the virus; however, while some patients respond to the treatment with interferon, others do not. In this research, the clinical study was combined with the mathematical model developed by Dr. Brodsky. The study identified 37 genes which are key for patient response to treatment.

"In the specific case of hepatitis C, we have now isolated the genes that show which patients will respond to treatment. Until now, all patients received treatment for an extended period of time without knowing whether or not they would respond. In the future, we hope to find other medications that will be more effective in activating all of the 37 genes." summarized Dr. Brodsky.

He further explained that this mathematical model is not limited to identifying the genes which fight viruses that attack the liver. It can also be applied further in the fields of medicine, biology and agriculture.

The results will be published in PLOS ONE.


Story Source:

The above story is based on materials provided by University of Haifa. Note: Materials may be edited for content and length.


Cite This Page:

University of Haifa. "Mathematical Model Identifies Genes Which Battle Hepatitis C." ScienceDaily. ScienceDaily, 19 July 2007. <www.sciencedaily.com/releases/2007/07/070719100323.htm>.
University of Haifa. (2007, July 19). Mathematical Model Identifies Genes Which Battle Hepatitis C. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/07/070719100323.htm
University of Haifa. "Mathematical Model Identifies Genes Which Battle Hepatitis C." ScienceDaily. www.sciencedaily.com/releases/2007/07/070719100323.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins